Ocular Science: Funding, Investors & Team (Sep 2026)
Ocular Sciences is a biotech company reducing dry eye and inflammation through post-operative care and provides cost-effective, efficacious products to physicians and their patients for surgical vision correction, myopia control. and the management of glaucoma and dry eye disease. The company focuses on the production of paradigm-shifting ophthalmic products that are easy to use, cost-effective, and promote patient compliance. Founded in 2015, Ocular Science is headquartered in Manhattan Beach, California.
Ocular Science has raised $16.5M across 1 funding round on record, the most recent an undisclosed round of $16.5M announced in Jan 2026.
That round is above the $8.0M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
Ocular Science Company Profile and Key Stats
Latest funding round on record: Jan 2026.
Ocular Science Funding Rounds
Ocular Science Founders and Leadership Team
No contact details are on record for this team yet.
Ocular Science Funding Compared to Other Biotechnology Startups
Ocular Science's latest round of $16.5M is above the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Ocular Science in Biotechnology and Manhattan Beach
Companies Similar to Ocular Science
Superluminal Medicines is a biotech company that specializes in rapidly developing new drugs through a…
Senticell's mission is to fully harness the unique immune and genetic functions of RBC to transform and treat…
ImmunoPhotonics, Inc. develops immunotherapy-based treatments for cancer. ImmunoPhotonics, Inc. has a…
EIT Pharma is a commercial-stage biotechnology company focuses on developing and commercializing…
Halia Therapeutics is a biopharmaceutical company in the preclinical stage that is developing new treatments…
Noveome Biotherapeutics, Inc. is an advanced biopharmaceutical company that focuses on groundbreaking…
XiltriX North America is an information technology company that specializes in monitoring, predictive…
Novir is an emerging diagnostic biotechnology company with an unmatched team of professionals and trusted…
Abcuro’s mission is to develop a new class of immune-modulatory bio-therapeutics for treating both…
Georgiamune Inc. is a privately-owned biotechnology company that specializes in advanced immunotherapy…
Bridge to Life was founded with the mission of improving organ transplants by licensing and developing new…
InduPro is a biotechnology firm that focuses on protein therapeutics and technologies related to cell-surface…
Ocular Science Funding FAQs
What does Ocular Science do?
Ocular Sciences is a biotech company reducing dry eye and inflammation through post-operative care and provides cost-effective, efficacious products to physicians and their patients for surgical vision correction, myopia control. and the management of glaucoma and dry eye disease. The company focuses on the production of paradigm-shifting ophthalmic products that are easy to use, cost-effective, and promote patient compliance. Founded in 2015, Ocular Science is headquartered in Manhattan Beach, California.
How much funding has Ocular Science raised?
Ocular Science has raised $16.5M across 1 round on record. The most recent is an undisclosed round of $16.5M announced in Jan 2026.
When did Ocular Science last raise funding?
Ocular Science's most recent funding round on record is an undisclosed round of $16.5M, announced in Jan 2026.
Who founded Ocular Science?
FundedIQ lists Anthony Sampietro (Founder) at Ocular Science.
Where is Ocular Science headquartered?
Ocular Science is based in Manhattan Beach, California, United States.
How many employees does Ocular Science have?
Ocular Science is in the 11-50 employee band.
How does Ocular Science's funding compare to other Biotechnology startups?
Ocular Science's latest round of $16.5M is above the $8.0M median round size for Biotechnology companies on FundedIQ across 4,182 tracked companies over the last two years.
About FundedIQ's Ocular Science Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Ocular Science is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.
Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.